phs000007.v30.p11
Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy
Mapping250K_Nsp
Mapping250K_Sty
Mapping50K_Hind240
Mapping50K_Xba240
|
phs000280.v5.p1
Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000090.v4.p1
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000209.v13.p3
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000200.v12.p3
Women's Health Initiative | Versions 1-11: passed embargo
Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000086.v3.p1
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0
ILLUMINA_Human_1M
|
phs000343.v3.p1
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000287.v6.p1
Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000594.v1.p1
A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs000577.v1.p1
UCDC Longitudinal Study | Version 1: passed embargo
| VDAS | 542 | Longitudinal | Links | |
phs000309.v3.p2
The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000001.v3.p1
NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1
Mapping50K_Hind240
Mapping50K_Xba240
|
phs000363.v17.p11
NHLBI Framingham SABRe CVD | Versions 1-17: passed embargo
| VDAS | 7558 | Cohort | | GeneChip Human Exon 1.0 ST Array
Custom Panel
TaqMan 350 MicroRNA Custom Panels
|
phs000592.v1.p1
Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias | Version 1: passed embargo
| VDAS | 341 | Longitudinal, Prospective | Links | |
phs000236.v2.p2
PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA) | Versions 1-2: passed embargo
| VDAS | 3595 | Longitudinal | Links | TaqMan OpenArrays: CALiCo ABD TaqMan Y1
TaqMan OpenArrays: CALiCo ABD TaqMan Y2
TaqMan OpenArrays: CALiCo AOD TaqMan Y1
TaqMan OpenArrays: CALiCo AOD TaqMan Y2
TaqMan OpenArrays: CALiCo DME TaqMan Y1
TaqMan OpenArrays: CALiCo DME TaqMan Y2
TaqMan OpenArrays: CALiCo Sequenom Y2
iSelect Custom Panel
|
phs001073.v1.p1
Epigenetic Analysis of Malnutrition | Version 1: passed embargo
| VDAS | 59 | Interventional, Randomized, Clinical Trial | | TruSeq ChIP
|
phs000578.v1.p1
Nondystrophic Myotonias | Version 1: passed embargo
| VDAS | 95 | Longitudinal | Links | |
phs000228.v4.p1
HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium
454 GS FLX Titanium
|
phs000018.v2.p1
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN | Versions 1-2: passed embargo
| VDAS | 1972 | Case-Control | Links | Mapping250K_Nsp
Mapping250K_Sty
|
phs000088.v1.p1
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK | Version 1: passed embargo
| VDAS | 1206 | Case-Control | Links | Mapping250K_Nsp
Mapping250K_Sty
|